Navigation Links
CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis
Date:3/29/2009

is in line with other marketed statins.

IMPORTANT SAFETY INFORMATION:

CRESTOR is indicated as an adjunct to diet to reduce elevated Total-C, LDL-C, ApoB, non-HDL-C, and TG levels and to increase HDL-C in adult patients with primary hyperlipidemia and mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis as part of a treatment strategy to lower Total-C and LDL-C to target levels. CRESTOR is not approved to prevent cardiovascular morbidity and mortality.

CRESTOR is contraindicated in patients with a known hypersensitivity to any component of this product, in patients with active liver disease, which may include unexplained persistent elevations of hepatic transaminase levels, in women who are pregnant or may become pregnant, and in nursing mothers.

Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including CRESTOR. These risks can occur at any dose level, but are increased at the highest dose (40 mg).

CRESTOR should be prescribed with caution in patients with predisposing factors for myopathy (eg, age Greater Than or Equal to 65 years, inadequately treated hypothyroidism, renal impairment). The risk of myopathy during treatment with CRESTOR may be increased with concurrent administration of some other lipid-lowering therapies (fibrates or niacin), gemfibrozil, cyclosporine, or lopinavir/ritonavir.

Therapy with CRESTOR should be discontinued if markedly elevated CK levels occur or myopathy is diagnosed or suspected. All patients should be advised to promptly report unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever. It is recommended that liver enzyme tests be performed before and at 12 weeks following both the initiation of therapy and any elevation of dose, and perio
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. CRESTOR(R) Reduced Risk of Blood Clots in the Veins
6. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
7. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
8. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
9. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
10. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
11. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
(Date:7/28/2015)... July 28, 2015  PD-Rx Pharmaceuticals, Inc., a ... it has partnered with Dobson Technologies, a fully-integrated ... Service (IaaS) product. PD-Rx is an ... the United States.  Using Dobson Technologies, IaaS solution ... business continuity, ensure regulatory compliance, and reduce operating ...
(Date:7/28/2015)... Fla. , July 28, 2015  For many ... their researchers, physicians and other inventors can be a ... market is difficult, and successes are rare. ... wants to change that. Medical Device Investments ... licensed from universities, hospitals and physicians. MDI develops, manufactures ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2PD-Rx Partners With Dobson Technologies 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... Texas Children,s Hospital and SynCardia Systems, Inc. announced today ... hospital to complete the first phase of certification to ... intends to use the Total Artificial Heart as a ... heart transplant as children and now require mechanical support ...
... 2011 As the biopharmaceutical marketplace has evolved, leading ... to change as well. Specifically, Market Research is shifting ... shaping strategic objectives for key commercial groups. ... increasingly use new and innovative tools such as Webcams ...
Cached Medicine Technology:Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 2Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 3Strategic Role Becoming Critical Part of Market Research Function 2
(Date:7/28/2015)... , ... July 28, 2015 , ... ... Total Heart Center at Memorial Regional Hospital, providing expert, streamlined total advanced heart ... be suited to provide extensive heart services under one roof, including the treatment ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces Skimmer Helper, a household invention that cleans pools efficiently - minus the ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It is ...
(Date:7/28/2015)... Florida (PRWEB) , ... July 28, 2015 , ... ... of patented products, announces Shelled Out, a new household invention that makes shelling ... earn $253.4 billion by 2020,” says Scott Cooper, CEO and Creative Director of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl Worley’s ... volunteers celebrate the 14th year of raising money for the Darryl Worley Foundation. ... for this year’s main concert Saturday, Oct. 3. , This year’s concert will ...
(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was the ... nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The system ... , The CoreValve® Evolut® R System was approved by the U.S. Food and Drug ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3
... on high alert Wednesday following the first confirmed outbreak of ... thousands of poultry were slaughtered in the Mekong// Delta. ... southern Ca Mau and Bac Lieu provinces, after tests on ... H5N1 strain of avian influenza., ,'We have begun to ...
... conducted by a US research company has highlighted the ... formidable health// problem facing society and their children today. ... 800 adults, found that nearly 27% named 'obesity', as ... insurance followed next with 16% strongly advocating action, ...
... North Carolina at Chapel Hill suggested that low LDL ... ,LDL stands for low density lipoprotein; the low ... Previously associations have been made between LDL and cardiovascular ... Parkinson's disease have a lower occurrence of heart attack ...
... the University of Texas M. D. Anderson Cancer Center suggest ... span of 40 years reduced the tumor growth in the// ... ,The Journal of the National Cancer Institute issued ... drug cromolyn is three times more effective than just the ...
... holding her husband’s hand, says a study. This is indeed ... of marriage// is losing ground. ,A new study ... Virginia, finds that women in a threatening situation show signs ... has been observed in brain scans. ,The researchers, ...
... Andy Kerr will receive Christmas cards from active members ... poor quality of treatment// offered to Chronic Obstructive Pulmonary ... charity suggests that clinical standards be set, to ensure ... ,COPD or Chronic Obstructive Pulmonary Disease is a term ...
Cached Medicine News:Health News:Low LDL Levels Lead to Parkinson's Disease 2Health News:Anti Allergy Drugs Reduce Tumor Growth 2Health News:Anti Allergy Drugs Reduce Tumor Growth 3
... with a curvature of 12 ... of the retina. Instrument shaft ... For cutting membranes adherent to ... for cutting in small folds ...
... Focus Diagnostics Rickettsia Indirect Immunofluorescence ... intended for the detection and ... antibodies to Spotted Fever and ... an in vitro aid in ...
... test for the detection and semi-quantitation of ... Encephalitis virus (SLE), Western Equine Encephalitis virus ... California Encephalitis/La Crosse virus (CE). Each kit ... spots of SLE, WEE, EEE, and CE ...
... antibody (IFA) test for the detection ... antibodies to the detection and semi-quantitation ... virus early antigens, both restricted (R) ... ten 12-well slides, FITC conjugate, positive ...
Medicine Products: